IDYA
IDEAYA BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
IDYA vs peer average
56/100
IDYA vs. peer average (B vs. B)
Grade spread
A 2 · B 4 · C 2 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
EXEL is the first available peer comparator.
Established oncology-focused commercial-stage company — useful comparator for post-approval commercialization dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IDYA
IDEAYA Biosciences
EXEL
Exelixis
Grade
B
A
Momentum
26
77
Value
41
65
Sentiment
100
49
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs EXEL
IDYA / EXEL
Grade Position
In line
IDYA vs. peer average (B vs. B)
56/100
Momentum
26
EXELValue
41
EXELSentiment
100
IDYARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IDYA
EXEL is the first peer returned for this comparison set.